For Patients

About NavDx
NavDx® is a clinically validated blood test for the early detection of HPV-associated cancers. Please fill out the form below if you are interested in learning more.
News & Publications

–HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch

–Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer

–Naveris, Inc. to provide NavDx® blood test to Cancer Centers of Excellence

–Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

–HPV blood test shows promise for tracking head and neck cancer after treatment

 

 

Follow us on: